— Know what they know.
Not Investment Advice

PRRUF OTC

Immutep Ltd
1W: -25.0% 1M: -25.0% 3M: -40.0% YTD: -90.6% 1Y: -84.2% 3Y: -85.0% 5Y: -88.5%
$0.03
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 39 · $44.2M mcap · 1.43B float · 0.0000% daily turnover · Short 74% of daily vol

Balance Sheet Trends

Total Assets
$83M -47.0% ▼
5Y CAGR: +0.3%
Total Liabilities
$22M +62.6% ▲
5Y CAGR: +19.9%
Shareholders Equity
$61M -57.2% ▼
5Y CAGR: -3.5%
Cash & Investments
$69M -47.0% ▼
5Y CAGR: +2.7%
Total Debt
$1M -35.6% ▼
5Y CAGR: -18.0%
Net Debt
-$68M -3.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$80M$123M$162M$67M$69M
Short-Term Investments$0$0$20M$62M$0
Cash & ST Investments$80M$123M$182M$130M$69M
Net Receivables$8M$8M$8M$7K$10M
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$11M$11K
Total Current Assets$91M$135M$191M$149M$81M
Property, Plant & Equip.$308K$469K$680K$569K$1M
Goodwill & Intangibles$11M$9M$8M$7M$1M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$496K$3M$1M$117K$51K
Total Non-Current Assets$11M$12M$10M$8M$3M
Total Assets$102M$147M$202M$157M$83M
— Liabilities —
Accounts Payable$3M$5M$4M$6M$6M
Short-Term Debt-$3M$0$0$1M$290K
Deferred Revenue$3M$0$0$0$0
Other Current Liabilities$3M$355K$429K$447K$8M
Total Current Liabilities$6M$10M$10M$13M$14M
Long-Term Debt$1M$835K$961K$0$0
Other Non-Current Liab.$117K$164K$211K$274K$7M
Total Non-Current Liabilities$2M$1M$2M$589K$8M
Total Liabilities$8M$11M$12M$13M$22M
— Equity —
Common Stock$367M$446M$542M$535M$547M
Retained Earnings-$302M-$340M-$383M-$444M-$520M
Accumulated OCI$29M$30M$30M$53M$35M
Total Stockholders Equity$94M$136M$190M$144M$61M
Total Liabilities & Equity$102M$147M$202M$157M$83M
— Key Metrics —
Total Debt$2M$1M$2M$2M$1M
Net Debt-$78M-$122M-$160M-$66M-$68M
Total Investments$0$0$20M$62M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms